RA
Rapport Therapeutics, Inc. Common Stock (RAPP) Earnings
NASDAQ·Healthcare·Biotechnology
$41.59
+1.92%
Mkt Cap $2.05B
EPS — Estimate vs Actual
Mkt Cap
$2.05B
P/E
—
Fwd P/E
—
P/S
102.30
Rev TTM
—
EPS TTM
-$2.60
NASDAQ·Healthcare·Biotechnology
$41.59
+1.92%
Mkt Cap $2.05B
Mkt Cap
$2.05B
P/E
—
Fwd P/E
—
P/S
102.30
Rev TTM
—
EPS TTM
-$2.60